Current status of autologous stem cell transplantation for multiple ...

More than 30 years after its introduction, autologous stem cell transplantation (ASCT) remains the standard of care for young patients with ...

Autologous Stem Cell Transplant for Multiple Myeloma

With autologous stem cell transplant (or bone marrow transplant), a patient's own healthy stem cells are used to replace that patient's diseased bone ...

Current Status of Autologous Stem Cell Transplantation in Relapsed ...

Tandem autologous transplantation has been used successfully in multiple myeloma patients and in the therapy of patients with germ cell tumors [72, 73] and has ...

Overcoming Barriers to Autologous Stem Cell Transplantation in ...

Autologous stem cell transplantation (ASCT) is a standard of care treatment for patients with multiple myeloma (MM). However, only 20% to ...

Overcoming Barriers to Autologous Stem Cell Transplantation in ...

Autologous stem cell transplantation (ASCT) is a standard of care treatment for patients with multiple myeloma (MM). However, only 20% to 30% of patients with ...

Use of Backup Stem Cells for Stem Cell Boost and Second ...

Autologous hematopoietic stem cell transplantation (ASCT) is a standard treatment for multiple myeloma (MM). Consensus guidelines recommend collecting ...

Autologous stem cell transplantation in patients older than 65 years ...

No statistically significant differences were found in the incidence of TRM between both groups at 100 days post-transplant (2% vs. 2.9%, p = ...

Autologous Stem-Cell Transplantation for Multiple Myeloma in the ...

Autologous stem-cell transplantation (ASCT) has been the standard treatment of MM in transplantation-eligible patients since the 1990s and its ...

Autologous Hematopoietic Stem Cell Transplantation for Patients ...

Autologous hematopoietic stem cell transplantation (AHSCT) is approved for the treatment of select solid tumors, autoimmune disorders, and most hematologic ...

Current status of autologous stem cell transplantation for multiple ...

At transplant, 10 (62%) patients obtained at least a very good partial response. Response after autoSCT (3 month) was at least VGPR in 6 (67%, CR=5) patients.

Multiple myeloma, high-dose treatment and autologous stem cell ...

High-dose chemo-radiotherapy with autologous stem cell transplantation (ASCT) has introduced the concept of complete remission for multiple myeloma, ...

Current status of haematopoietic autologous stem cell ...

The use of autologous haematopoietic stem cell transplantation (ASCT) has increased considerably in lymphoid malignancies in the last decade ...

Autologous stem cell transplant - Type - Mayo Clinic

An autologous stem cell transplant uses healthy blood stem cells from your own body to replace bone marrow that's not working properly.

Autologous Stem Cell Transplant - Cleveland Clinic

An autologous stem cell transplant may be a treatment option for some blood cancers. It works by using your own healthy stem cells to replace cells that cancer ...

Autologous Hematopoietic Stem Cell Transplantation for Multiple ...

International Myeloma Working Group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for ...

Long-term outcomes after autologous stem cell transplantation for ...

Cure models support the potential for cure, ranging from 6.3% to 31.3%, depending on the year of treatment, with 10.0% to 18.6% of patients achieving their ...

Paper: Outcomes after Autologous Stem Cell Transplant in Patients ...

early autologous stem cell transplant (ASCT) in multiple myeloma (MM), some patients are electing to proceed with transplant at relapse ...

Multiple myeloma: Autologous stem cell transplants explained

Neither form of transplant is guaranteed to succeed. Autologous transplants can keep a person with MM in remission for a long time — possibly ...

Role of autologous stem cell transplantation in multiple myeloma

Recent randomized trials suggest a survival benefit with tandem ASCT, notably for patients failing to achieve a very good response to initial ...

The Role of Autologous Stem Cell Transplantation in the Treatment ...

Of note, the proportion of patients achieving MRD-negative status was higher in the RVd + ASCT versus RVd-alone arm in both DETERMINATION (54% vs. 40% at the ...